Skip to main content
. 2021 Apr 21;7(17):eabf4865. doi: 10.1126/sciadv.abf4865

Fig. 6. Hepatic secretory ability is altered upon the loss of FXR and SHP.

Fig. 6

(A) Circulating levels of albumin are reduced in LDKO mice, with no significant change in hepatic albumin levels (n = 4 to 9 mice per group, Student t test, **P < 0.01). Whereas serum levels of (B) cholesterol and (C) triglycerides are higher in LDKO mice (n = 5 to 9 mice per group; Student t test, **P < 0.01 and ****P < 0.0001). (D) Schematic figure displaying unstacked Golgi and hyperbranched N-glycans in an LDKO hepatocyte.